Malignancies in Inflammatory Bowel Disease
Open Access
- 14 August 2020
- journal article
- review article
- Published by S. Karger AG in Digestion
- Vol. 101 (Suppl. 1), 136-145
- https://doi.org/10.1159/000509544
Abstract
Background: Inflammatory bowel disease (IBD) is a chronic inflammatory disorder, primarily of, but not restricted to, the gut. Association between IBD and cancer has been clearly established and is uniformly accepted. Summary: IBD patients are at particular risk for intestinal and extraintestinal cancers. There are 2 underlying mechanisms: (1) IBD-related inflammation triggers initiation and progression of tumor formation. This particularly results in the development of colorectal cancer, small bowel adenocarcinoma, intestinal lymphoma, anal cancer, and cholangiocarcinoma. (2) Immunosuppressive drugs exhibit carcinogenic properties such as shown for azathioprine and anti-TNF promoting lymphoproliferative malignancies and melanoma and nonmelanoma skin cancer. However, within the last years, IBD-related cancer incidence and prevalence have been decreasing, which might be attributed to better treatment options and surveillance strategies. Moreover, novel biological drugs have been introduced in clinical practice and have dramatically changed long-term IBD management. Therefore, we sought to summarize up-to-date knowledge about (1) overall cancer risk; (2) risk and protective factors for cancer development; and (3) inflammation- and immunosuppression-related malignancies in the current anti-TNF era of IBD. Key Messages: Recent studies and meta-analyses questioned the excess rates of cancer in IBD patients. However, IBD still is associated with cancer development due to ongoing intestinal inflammation and the use of potential carcinogenic drugs. Patients should be educated about the increased risk of cancer with IBD and IBD drugs. However, they should also be informed that most malignancy subtypes are possibly preventable by controlling intestinal inflammation and by using adequate screening strategies.Keywords
This publication has 73 references indexed in Scilit:
- Medical Risk Factors Associated with Cholangiocarcinoma in Taiwan: A Population-Based Case-Control StudyPLOS ONE, 2013
- Ulcerative Colitis–Associated Colorectal Cancer Arises in a Field of Short Telomeres, Senescence, and InflammationCancer Research, 2011
- Inflammatory Bowel DiseaseAnnual Review of Immunology, 2010
- Immunity, Inflammation, and CancerCell, 2010
- Colonoscopic surveillance improves survival after colorectal cancer diagnosis in inflammatory bowel diseaseBritish Journal of Cancer, 2009
- Immune escape by Epstein–Barr virus associated malignanciesSeminars in Cancer Biology, 2008
- PTCH mutations in basal cell carcinomas from azathioprine-treated organ transplant recipientsBritish Journal of Cancer, 2008
- Immunosuppressive Therapy and Malignancy in Organ Transplant RecipientsDrugs, 2007
- Cancer despite immunosurveillance: immunoselection and immunosubversionNature Reviews Immunology, 2006
- Ueber bewegliche thierische ZellenVirchows Archiv, 1863